Eastgate Biotech Corp. (OTCMKTS:ETBI – Get Free Report) crossed above its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of $0.00 and traded as high as $0.00. Eastgate Biotech shares last traded at $0.00, with a volume of 1,000 shares trading hands.
Eastgate Biotech Trading Up 3,900.0%
Eastgate Biotech Company Profile
Eastgate Biotech Corp., a development stage company, develops novel formulations of natural compounds and pharmaceutical products. The company is developing pharmaceutical products, such as Lorazepam oral spray for acute seizures emergency treatment; Ketoconazole 2% topical ointment for treatment of skin fungal infections; and Metformin chewable/ sublingual tablets for treatment of type 2 diabetes.
Further Reading
- Five stocks we like better than Eastgate Biotech
- What is a penny stock? A comprehensive guide
- Rigetti Computing: Cantor’s Bullish Call May Be Just the Start
- How to Invest in the FAANG Stocks
- Big Bank Buybacks: Morgan Stanley, Citi, & Wells Fargo Lead
- 3 Small Caps With Big Return Potential
- 3 Top Stocks Under $20 Riding the “Made in America” Wave
Receive News & Ratings for Eastgate Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eastgate Biotech and related companies with MarketBeat.com's FREE daily email newsletter.
